Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Capital Reinvestment Ratio
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥837.18 Million) in capital expenditures (CN¥152.89 Million). Check how tangible is Anhui Huaren Health Pharmaceutical Co. L's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Capital Reinvestment Ratio (2021–2025)
This chart tracks Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see Anhui Huaren Health Pharmaceutical Co. L operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Year-by-year Capital Reinvestment Ratio for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025. See 301408 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | CN¥837.18 Million | CN¥152.89 Million | ▼ -35.1% |
| 2024 | 0.28x | CN¥571.76 Million | CN¥160.89 Million | ▼ -82.9% |
| 2023 | 1.65x | CN¥131.37 Million | CN¥216.31 Million | ▲ +173.2% |
| 2022 | 0.60x | CN¥173.84 Million | CN¥104.77 Million | ▲ +150.3% |
| 2021 | 0.24x | CN¥140.82 Million | CN¥33.91 Million | — |